Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

Woolly mammoths went extinct around 4,000 years ago, but scientists claim America will soon see the prehistoric animal in 2028. Colossal Biosciences, a Texas-based biotechnology and genetic ...

The Woolly mammoth could roam the planet once again – in just four years. Colossal Biosciences, a de-extinction company, has announced its dedicated team achieved a world-first breakthrough by ...

Perhaps known best for its efforts to bring back the woolly mammoth, Dallas-based Colossal’s core mission is preserving biodiversity—the variety of life in ecosystems. And bio ...

The bones belonged to dozens of hunted species, the institute said, including woolly mammoths. The skeletons of at least 13 mammoths were discovered at the site, dating to a period researchers ...

Instead of dinosaurs, Colossal has set its sights on more recently lost species including the dodo, the thylacine — also known as the Tasmanian tiger– and the woolly mammoth. The last ...

Artwork of the woolly mammoth (Mammuthus primigenius), or tundra mammoth. - Image: MARK GARLICK/SCIENCE PHOTO LIBRARY (Getty Images) Colossal Biosciences, the world’s first company dedicated to ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.